Close

19 marzo, 2021

Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study

First long-term Wuhan seroprevalence study finds 6.9% of population had antibodies against COVID-19 by April 2020—with 82% of cases asymptomatic. 40% developed neutralising antibodies lasting at least 9 months. Read https://hubs.li/H0Jxm4g0

 


Créditos: Comité científico Covid

Deja un comentario

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *